Abstract:BackgroundA significant number of patients with COVID-19 experience prolonged symptoms, known as Long COVID. Few systematic studies have investigated this population, particularly in outpatient settings. Hence, relatively little is known about symptom makeup and severity, expected clinical course, impact on daily functioning, and return to baseline health.MethodsWe conducted an online survey of people with suspected and confirmed COVID-19, distributed via COVID-19 support groups (e.g. Body Politic, Long COVID Support Group, Long Haul COVID Fighters) and social media (e.g. Twitter, Facebook). Data were collected from September 6, 2020 to November 25, 2020. We analyzed responses from 3762 participants with confirmed (diagnostic/antibody positive; 1020) or suspected (diagnostic/antibody negative or untested; 2742) COVID-19, from 56 countries, with illness lasting over 28 days and onset prior to June 2020. We estimated the prevalence of 203 symptoms in 10 organ systems and traced 66 symptoms over seven months. We measured the impact on life, work, and return to baseline health.FindingsFor the majority of respondents (>91%), the time to recovery exceeded 35 weeks. During their illness, participants experienced an average of 55.9+/- 25.5 (mean+/-STD) symptoms, across an average of 9.1 organ systems. The most frequent symptoms after month 6 were fatigue, post-exertional malaise, and cognitive dysfunction. Symptoms varied in their prevalence over time, and we identified three symptom clusters, each with a characteristic temporal profile. 85.9% of participants (95% CI, 84.8% to 87.0%) experienced relapses, primarily triggered by exercise, physical or mental activity, and stress. 86.7% (85.6% to 92.5%) of unrecovered respondents were experiencing fatigue at the time of survey, compared to 44.7% (38.5% to 50.5%) of recovered respondents. 1700 respondents (45.2%) required a reduced work schedule compared to pre-illness, and an additional 839 (22.3%) were not working at the time of survey due to illness. Cognitive dysfunction or memory issues were common across all age groups (~88%). Except for loss of smell and taste, the prevalence and trajectory of all symptoms were similar between groups with confirmed and suspected COVID-19.InterpretationPatients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.FundingAll authors contributed to this work in a voluntary capacity. The cost of survey hosting (on Qualtrics) and publication fee was covered by AA's research grant (Wellcome Trust/Gatsby Charity via Sainsbury Wellcome center, UCL).

Exploring Long Covid: An Unexpected Research Journey in Family Medicine Leading to Translational Research

Translating insights into therapies for Long Covid

A call from patient-researchers to advance research on long COVID

Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Charting the COVID Long Haul Experience -- A Longitudinal Exploration of Symptoms, Activity, and Clinical Adherence

An exploration of the experiences and self-generated strategies used when navigating everyday life with Long Covid

Attributes and predictors of long COVID

Living with Long COVID: A Longitudinal Interview Study of Individuals' Communicative Resilience Through the "Long Haul"

Burnout, Compassion Fatigue and the Long Haul of Caring for Long COVID

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions

A practical framework for Long COVID treatment in primary care

Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study

The long COVID research literature

A Practical Approach to Tailor the Term Long COVID for Diagnostics, Therapy and Epidemiological Research for Improved Long COVID Patient Care

Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols

Designing and optimizing clinical trials for long COVID

Using real-world data to accelerate the search for long COVID therapies

Long Neuro-COVID-19: Current Mechanistic Views and Therapeutic Perspectives

Unraveling Post-COVID-19 Immune Dysregulation Using Machine Learning-based Immunophenotyping